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Key message   
The commonly used definition of repeated implantation failure based on three failed IVF attempts 
leads to an exceedingly high number of false–positive diagnoses. 
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Abstract 
The most common definition of repeated implantation failure (RIF) is the failure to obtain a clinical 
pregnancy after three completed IVF cycles. This definition, however, may lead to misuse of the 
diagnosis. To disentangle this, we set up a mathematical model based on the following main 
assumptions: rate of success of IVF constant and set at 30%; and RIF postulated to be a 
dichotomous condition (yes or no) with a prevalence of 10%. On this basis, the expected cumulative 
chance of pregnancy after three and six cycles was 59% and 79%, respectively. Consequently, the 
false–positive rate of a diagnosis of RIF is 75% and 51%, respectively. Increasing the rate of 
success of IVF or the prevalence of RIF lowers but does not make unremarkable the rate of false–
positive diagnoses. Overall, this model shows that the commonly used definition of RIF based on 
three failed attempts in a standard population with good prognosis leads to over-diagnosis and, 
potentially, to over-treatments.  
 
KEYWORDS: repeated implantation failure, IVF, model, false positive
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<A>Introduction 
Repeated implantation failure (RIF) is mainly defined as the failure to obtain a clinical pregnancy 
after three consecutive IVF attempts, in which one to two embryos of high-grade quality are 
transferred in each cycle (Simon and Laufer, 2012). The precise definition, however, remains 
controversial, and several other different suggestions have been made. Considering the number of 
failed cycles, three completed IVF attempts is the most commonly used threshold (Polanski et al., 
2014); however, in a minority but not negligible proportion of studies, a diagnosis is made after 
only two cycles (Polanski et al., 2014).  It has been suggested that the focus should be on the 
number of embryos, and a definition of RIF has been proposed as the ineffective transfer of a total 
of 10 cleavage stage embryos or four blastocysts (Polanski et al., 2014). The definition of ‘good-
quality embryos’ that is commonly used in these proposals is also a matter of concern (Coughlan et 
al., 2014a). In general, all the suggested definitions derive from expert opinions but lack robust 
scientific basis. 
From a clinical viewpoint, RIF represents a challenging and frustrating condition. Physicians have 
to handle stressed couples who are frequently overwhelmed by the situation (Coughlan et al., 
2014b). Failure to achieve pregnancy is one of the main reasons explaining the high rate (up to 
50%) of couples who drop-out from IVF programmes after fewer than three cycles (Gameiro et al., 
2012; Gameiro et al., 2013). Those who do not give up desperately ask for more in-depth diagnostic 
investigations or adjuvant treatments aimed at improving their chances of pregnancy. Even if the 
pregnancy rate was not shown to markedly reduce with the number of attempts (Luke et al., 2012; 
McLernon et al., 2016), physicians frequently irrationally comply with these requests. This 
common clinical attitude is humanly understandable and may ultimately be helpful in improving 
long-term adherence to the IVF programme. On the other hand, it may waste financial resources 
and expose patients to undue additional risks. 
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In fact, given the relatively low rate of IVF success, three failed attempts has to be expected in a 
large proportion of couples even in the absence of any real obstacle to the success of the procedure. 
Even if RIF presumably does exist, currently used definitions may be insufficiently stringent. This 
can hamper research in the field and may lead to over-diagnosis and, potentially, to over-treatments. 
In this study, we aim to show that RIF represents a misused diagnosis using a mathematical model. 
 
<A>Materials and methods 
The primary aim of the mathematical model that we have elaborated was to evaluate the effect of 
the number of IVF cycles on the capacity to discriminate between couples who are actually affected 
by RIF (women who will never achieve pregnancy even after an infinite number of IVF attempts) 
from women who do not conceive just because of statistical misfortune.   
The assumptions made for the model were as follows: rate of success of IVF (cumulative chance of 
pregnancy per oocyte retrieval) is constant; rate of success of IVF in women without RIF problems 
is 30% (EIM, 2016); RIF postulated to be a constant and dichotomous (yes or no) condition; and 
prevalence of RIF is 10%. 
 
In fact, the real prevalence of RIF is unknown and arbitrarily set at 10% (but then varied in 
sensitivity analyses from 5 to 25%). Even if a precise estimation of this prevalence cannot be 
extrapolated from published research, data from two studies reporting on the cumulative chance of 
pregnancy after seven to eight treatments cycles suggest that the frequency of this condition is at 
least below 20% (Luke et al., 2012; McLernon et al., 2016). Indeed, in both studies, the cumulative 
chances excluding drop-outs (optimal estimate) exceeded 80%. 
 
In our model, the analyses included up to six treatment cycles. Only women without RIF 
(corresponding to 90% of the cohort entering the IVF programme as 10% were affected by RIF) 
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could become pregnant. The IVF success rate (30% in the basal model) thus applied only to women 
who had not experienced RIF remaining in the cohort (those achieving pregnancy in one specific 
cycle were obviously excluded from the remaining cohort). For instance, in the basal model, the 
chances of pregnancy at first cycle was 27% (30% of the 90% of women not affected by RIF). 
 
The false–positive rate of a diagnosis of RIF (FP) was calculated using the rate of RIF (A) and the 
rate of women without RIF who have not yet conceived because of statistical misfortune (B). 
Specifically, the formula was as follows: 
 FP =  B / (A + B) 
Sensitivity analyses was carried out on the rate of success of IVF (10–50%) and on the prevalence 
of RIF (5–25%). 
 
<A>Results 
The main results of the application of our model are presented in Figure 1. Women with RIF will 
never become pregnant regardless of the number of IVF attempts: therefore, even if they represent 
10% of the initial cohort of women entering the programme, the relative proportion progressively 
increases with the number of attempts (women achieving pregnancy drop out). As a consequence, 
even if women not affected by RIF have a constant chance of becoming pregnant of 30% per cycle, 
the chances of pregnancy progressively decreases with the number of attempts. Specifically, the 
pregnancy rates are 27%, 26%, 25%, 23%, 20% and 18% at the first, second, third, fourth, fifth and 
sixth cycles, respectively (Figure 1, upper panel). The consequent cumulative chances of pregnancy 
grows progressively more slowly with the number of cycles, being 27%, 46%, 59%, 68%, 75% and 
79% after first to sixth cycles, respectively (Figure 1, lower panel). Consequently, the false–
positive rate of a diagnosis of RIF is 86%, 81%, 75%, 68%, 60% and 51%, respectively. In other 
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words, couples can be erroneously labelled with a diagnosis of RIF in four out of five cases after 
two cycles, three out of four cases after three cycles and in one out of two cases after six cycles. 
Results  from the two planned sensitivity analyses are presented in Figure 2. Increasing the rate of 
success of IVF from 10% to 50% lowers the rate of false–positive diagnosis of RIF. Specifically, 
the rate decreases from 88% to 69% after two cycles, from 87% to 53% after three cycles and from 
83% to 12% after six cycles (Figure 2, upper panel). Modifying the rate of RIF in the population 
from 5 to 25% also affects the accuracy of the diagnosis of RIF. Specifically, the rate of false– 
positive diagnoses decreases from 90% to 60% after two cycles, from 87% to 51% after three cycles 
and from 69% to 26% after six cycles (Figure 2, lower panel).  
 
<A>Discussion 
A reliable diagnosis of RIF cannot be drawn after only two to three IVF cycles. Accuracy remains 
low even when strictly considering the definition proposed by Simon and Laufer (2012) of at least 
three complete IVF cycles transferring one or two high-quality embryos. Indeed, the rate of false– 
positive diagnoses after three IVF cycles remains above 50% in all sensitivity analyses. The 
diagnosis actually becomes more reliable after six cycles. 
The model seems to be sensitive to the rate of success of the procedure. The diagnosis of RIF may 
be more reliable in patients who face chances of success up to 50%,  for example, young women 
with appropriate ovarian reserve and those undergoing oocyte donation (Van Voorhis, 2007). 
Conversely, the diagnosis cannot actually be made in women with poor prognosis whose chances of 
pregnancy are below 10%, i.e. women aged over 40 years (Van Voorhis, 2007). In clinical practice, 
however, precisely discerning between good- and poor-prognosis couples is not always simple. The 
chances of pregnancy depend on patients’ characteristics, such as age, ovarian reserve and cause of 
infertility, and IVF local policy, such as preimplantation genetic screening, extended culture, and 
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number of transferred embryos; however, a precise personalized estimate remains difficult (van 
Loendersloot et al., 2014; McLernon et al., 2016b; Sarais et al., 2016). Most importantly, the 
definition of good-prognosis women, and thus the reliability of RIF diagnosis, should also be 
adapted to the local context given the elevated inter-centre variability of the effectiveness of IVF 
(Lintsen et al., 2010). Finally, it is worthwhile noting that the diagnosis of RIF is facilitated if the 
condition has a high prevalence. Again, accuracy remains modest up to a prevalence of 25%, a 
presumably unrealistic rate considering that the cumulative chances of pregnancy after seven to 
eight cycles of IVF have been shown to be over 80% (Luke et al., 2012; McLernon et al., 2016a). 
The clinical relevance of a false–positive diagnosis depends on the clinical context.  If the causes 
can be reliably identified with cheap and safe investigations, and an effective and safe treatment is 
available, the importance decreases. Conversely, a high rate of false–positive diagnoses is 
unacceptable if the identification of the causes requires expensive, debated and risky investigations 
or if there is no definite evidence of effective treatments. Unfortunately, the IVF scenario is more 
evocative of the latter rather than of the former situation.  
Discussing all the possible causes of RIF, the related diagnostic instruments and the possible 
therapeutic solutions is beyond the scope of our study. These arguments have been exhaustively 
reviewed recently (Simon and Laufer, 2012; Coughlan et al., 2014a; de Ziegler et al., 2016; Zohni 
et al., 2016). A tentative list of possible factors interfering with embryo implantation and possible 
treatments is shown in Table 1 (Johnson et al., 2010; Practice Committee of ASRM, 2012; Brady et 
al., 2013; Li et al., 2013; Vercellini et al., 2014; Bosteels et al., 2015; Crawford and Steiner, 2015; 
Practice Committee of ASRM, 2015; Ata and Urman, 2016; de Ziegler et al., 2016; Ko et al., 2016;  
Practice Committee of ASRM, 2016; Robertson et al., 2016; Zuini et al., 2017). Of relevance here 
is that factors that are well-known to interfere with embryo implantation, and that are amenable to 
effective, economic and safe therapies, deserve to be identified and treated before embarking on an 
IVF programme. In fact, there is a general consensus that conditions such as smoking, obesity, 
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hydrosalpinx, uterine septum, endometrial polyps and submucosal fibroids type 0 and 1 should be 
corrected before starting IVF rather than after two or three failed attempts (Johnson et al., 2010; 
Practice Committee of ASRM, 2012; Brady et al., 2013; Practice Committee of ASRM, 2015; 
Practice Committee of ASRM, 2016). Once these factors are excluded (Table 1), one has to 
recognize that the remaining points are all controversial. Their role in the pathogenesis of RIF is 
debated or there is no demonstrated effective treatment. Oocyte donation represents an exception, 
but the validity of this option has to be balanced with the values and preferences of the patients.  
Even if smoking, obesity, hydrosalpinx, uterine septum, endometrial polyps and submucosal 
fibroids are detrimental conditions that should be corrected before starting treatment cycles, some 
couples may be initially non-compliant, and may choose to directly enter the IVF  programme. In 
these cases, physicians may consider re-discussing the opportunity of these interventions in couples 
who have experienced repeated failures. This upsetting clinical situation might improve adherence, 
particularly in challenging situations, such as when patients are required to stop smoking or lose 
weight. 
Some limitations of our model should be acknowledged. First, as for all models, the figures 
emerging from our analysis should be viewed as a mere estimation of the reality. Albeit practically 
complex, confirmation from real-word data is warranted. On the other hand, the robustness of the 
sensitivity analyses tends to support the reliability of the model. In fact, even in good-prognosis 
couples, setting the threshold at three failed cycles still exposes women to a significant risk of 
undue diagnoses of RIF (>50%). Similarly, the higher the rate of RIF, the lower the rate of false– 
positive diagnosis but, again, even in the extreme scenario of a prevalence of RIF of 25%, the rate 
of false–positive diagnoses after three cycles remains above 50%. 
Second, a possible point of concern is the choice to consider RIF as a dichotomous and permanent 
condition, i.e. as a present or absent situation. From a biological perspective, it would be more 
plausible to consider RIF as a continuous condition varying from a weak effect (implantation can 
Author: would ‘value’ be a 
more appropriate word than opportunity? 
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occur but with a slightly lower chance) up to a definite detrimental effect (implantation will never 
occur, as it is stated in our model). Noteworthy, a reduced rate of implantation secondary to poor 
endometrial preparation or excess oestrogen effect or some other temporal factor that is not 
constitutive may indeed be remediable. Introducing a gradient effect in our analysis would lead to a 
significant complication of the model. In this context, it has to be pointed out that the scenario on 
the accuracy of the diagnosis could be worse if RIF is considered a continuous condition. The 
number of IVF cycles needed to draw a reliable diagnosis would need to be increased. On the other 
hand, one may appeal for a more clinical and pragmatic vision of RIF. The crux of the matter is the 
interpretation of the condition.  If one restricts RIF to those who have a permanent block to embryo 
implantation, then the prevalence is likely to be low, and the number of cycles needed to reach the 
diagnosis is inevitably high. If one widens the definition based on everyday clinical practice 
(couples are generally upset after two or three failed cycles and strongly request for additional 
investigations and treatments), this may be more patient-centered but may expose couples to undue 
risks and useless additional expenditure. The theoretical model presented in our study cannot 
provide a definite solution. Our main aim was to warn the scientific community and stakeholders on 
the potential risks of a simplistic definition of RIF. 
The observations emerging from our model have some relevant implications. First, they strengthen 
the need for an appropriate selection of the characteristics of the participants to be included in future 
studies of RIF. The use of six failed cycles in a population of very good prognosis may be idealistic 
but, on the other hand, selection criteria are essential if the scientific community aims at adequately 
investigating the pathogenesis and possible treatment of RIF. The inclusion of an exceedingly high 
proportion of normal patients may significantly dilute the results of observational and interventional 
studies. Even if more stringent criteria may markedly shrink the number of participants, researchers 
should aim at multicentre collaborations rather than incongruously widening these criteria. On the 
basis of our data, and accepting the inclusion of half non-affected patients, the possible definition of 
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RIF could be three failed IVF cycles in very good prognosis patients (50% expected rate of success) 
or six failed cycles in a normal IVF population (30% expected rate of success). 
Second, our results may have some practical clinical implications. Physicians and patients have to 
adequately cope with the somehow cruel rules of statistics. Patients should be informed in-depth of 
the relatively low rate of success of IVF and the importance of persevering if they want to succeed. 
Moreover, physicians have to simplify the procedure of IVF as much as possible to reduce the 
general burden, make the procedure more friendly and ultimately improve adherence. Much 
attention should be paid to costs, regimen of stimulation, cycle monitoring and safety. Handling the 
psychological fragility of the couple facing this challenging situation is another independent 
important aspect. In fact, most couples experiencing repeated failures do not accept a comment ‘that 
this happens’. Most will ask, if not demand, what possible scientific basis there might be for 
understanding and treating the failure they have experienced. The recently increased experience of 
patients who are told that ‘perfect genetically normal’ embryos are being transferred who fail to 
achieve pregnancy may have even worsened the situation.  These patients will especially demand a 
further exploration of the reasons for failure, now that the time honored genetic reason for failure 
has been, supposedly, eliminated. In general, by not responding to this request for explanations, a 
clinician will risk losing his or her patient and thus impair the ultimate chance to achieve the goal. 
Physicians cannot deny a patient's experience and are called here to a challenging task, i.e. finding 
out the subtle equilibrium between rationality and psychology. The web-mediated exposure to the 
mermaid melodies on new ‘magic’ solutions do not facilitate this task.  
In this context, we plea for a less stringent interpretation of RIF. Regardless of the precise number 
of cycles needed for the definition, RIF should not be viewed as a diagnosis but, instead, as a 
condition at increased risk of having a diagnosis that may interfere with implantation. Women with 
repeated failures should not be labelled with the diagnosis of RIF, but, conversely, as women with a 
condition meriting re-evaluation. In other words, RIF actually identifies a population that may 
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require more attention and, if needed, further testing to rule out a possibly treatable diagnosis. In 
general, the nature of screening requires high sensitivity and low specificity. On this basis, one 
could accept the currently used definitions of RIF. On the other hand, a diagnostic test requires high 
specificity to be a ‘gold standard’ and enter clinical practice. Prescribing tests of debatable 
accuracy, unlinked to effective therapies, or both, is questionable. Physicians should clearly keep in 
mind these aspects when managing couples with repeated failures and patients should be informed 
in-depth about the clinical and statistical logics that are behind their condition. Targeting patients 
with a diagnosis of RIF without explaining to them the overall logic behind this situation may be 
frustrating and even stigmatizing. 
In conclusion, the current definition of RIF contrasts with the basic rules of statistics. Researchers 
have to deal with the intrinsic uncertainty of this diagnosis to design better studies aimed at 
investigating the causes and treatments of RIF. Moreover, physicians should also have a clear and 
realistic view of RIF to improve their ability to handle this clinically demanding situation. Of 
possible relevance here is clearly explaining a priori to the couples the intrinsic statistical rules of 
IVF (a procedure with a relatively low chance of pregnancy requiring multiple attempts) and 
recognizing RIF as a screening condition rather than a definite diagnosis. Physicians should keep in 
mind that the clinical uncertainty surrounding RIF is potentially risky because affected couples are 
vulnerable.  
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Figure 1: Relationship between pregnancy rate and rate of repeated implantation failure (RIF). 
According to the basal assumptions of the model, the prevalence of RIF and the chance of 
pregnancy in the no-RIF population were constant and set at 10% and 30%, respectively. The upper 
panel shows the chances of pregnancy per cycle according to the number of attempts. The lower 
panel illustrated the cumulative chances of pregnancy with the number of attempts.  
 
Figure 2: Results  from the two sensitivity analyses on the rate of IVF success and on the 
prevalence of repeated implantation failure (RIF). Five different rates were assessed for the two 
considered variables. In the upper panel, the rate of success of IVF was modified from 10% to 50%. 
In the lower panel the prevalence of RIF was modified from 5 to 25%. CPR, clinial pregnancy rate; 
ICSI, intracytoplasmic sperm injection. 
 
 
Typesetter: please insert 
en rule between false and positive; change 
hyphen between IVF and ICSI to en rule;  
insert spaces either side of an equal sign;  
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Table 1. Possible causes and treatments of repeated implantation failure.
a 
Cause 
Causal 
relation 
Diagnosis Therapy 
Therapy effective for 
RIF 
Main publications
b
 
      Lifestyle factors 
     Smoking Plausible Anamnesis Stop smoking Plausible Practice Committee of ASRM, 2012  
Obesity Debated Weight and height Weight loss Debated Practice Committee of ASRM, 2015  
      Gamete quality 
     Oocyte Plausible None Oocyte donation Yes Crawford and Steiner , 2015  
Spermatozoa Plausible DNA Fragmentation Testicular-epidydimal extraction Debated Zini et al., 2017  
      Uterine factors 
     Septate uterus Plausible 2D/3D-US Hysteroscopy Debated Practice Committee of ASRM, 2016  
Endometrial polyps Plausible 2D/3D-US or SIS Hysteroscopy Yes Bosteels et al., 2015  
Submucosal fibroids Plausible 2D/3D-US or SIS Hysteroscopy Yes Bosteels et al., 2015  
Intramural fibroids Debated 2D-US Laparoscopy/laparotomy Debated Brady et al., 2013  
Intrauterine adhesions Debated SIS Hysteroscopy Debated Bosteels et al., 2015  
Adenomyosis Debated 2D/3D-US Progestins or GnRHa Debated de Ziegler et al., 2016  
Molecular alterations Debated None Endometrial scratching Debated Ko and Ng, 2016  
      Adnexal pathologies 
     Hydrosalpinx Plausible 2D-US or HyCoSy Laparoscopy (salpingectomy) Yes Johnson et al., 2010  
Endometriosis Debated 2D-US Laparoscopy Debated Vercellini et al., 2014  
      Other 
     Thrombophylia Debated Blood tests Aspirin-heparin No Ata and Urman, 2016  
Immunological factor Debated None Corticosteroids, IVIG Debated Li et al., 2013; Robertson et al., 2016 
            
a
A tentative list of causes and treatments associated with a global judgment of the available evidence. For more in-depth systematic reviews, see Simon and Laufer (2012), 
Coughlan et al. (2014a), Zohni et al. (2016) and de Ziegler et al. (2016). 
b
If available, reviews were preferred. 
2D-US, two dimensional ultrasound; 3D-US: three dimensional ultrasound; GnRHa, Gonadotrophin-releasing hormone agonist; HyCoSy, hystero-salpingo contrast sonography; 
IVIG, intravenous immunoglobulin; RIF, repeated implantation failure; SIS, saline infusion sonography. 
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Figure 2. 
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